Systemic lupus erythematosus.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002908:Chronic Disease; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007239:Infections / Q000150:complications; D007674:Kidney Diseases / Q000150:complications; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D008268:Macular Degeneration / Q000139:chemically induced; D008297:Male; D011247:Pregnancy
D000305:Adrenal Cortex Hormones; D000962:Antimalarials; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents